We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Myelin Volume Measurement Tool Receives CE Mark

By HospiMedica International staff writers
Posted on 25 Apr 2017
A tool that can be used for rapid quantification of the estimated myelin volume in the brain for diagnostic imaging has been awarded the CE-mark (Conformité Européenne) for clinical use in Europe.

According to the developer of the post-processing software, the tool is compatible with Magnetic Resonance (MR) scanners from leading vendors.

The Rapid Estimation of Myelin for Diagnostic Imaging (REMyDI) tool is part of the SyntheticMR SyMRI NEURO REMyDI post-processing software package. More...
Myelin quantification enables clinicians to monitor myelin degeneration in patients with neurodegenerative disorders, and diseases that cause brain demyelination. Clinicians can also use the tool to follow myelination in the developing brain. The new REMyDI feature will provide clinicians with automatic myelin volume measurement using data from a single 5-6-minute quantitative MRI scan. Post-processing is automatic and takes less than 10 seconds to complete.

The SyMRI software package enables clinicians to capture multiple image contrasts in one MR scan. The contrast can be adjusted following the scan to create additional images. The system provides automatic segmentation of brain tissue for objective decision support based on quantitative data. Scanner settings can be matched between scans to enable accurate comparison between exams. The images can also be matched with previous images, and conventional protocols. The SyMRI software package is CE-marked, and is pending 510(k) approval from the US Food and Drug Administration (FDA).


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
12-Channel ECG
CM1200B
Syringe Pump
SP50 Series
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.